_version_ 1784740254114119680
author de Almeida e Borges, Valéria Ferreira
Cotrim, Helma Pinchemel
Ferreira, Marcelo Simão
Caetano Marins, José Humberto
Gomes Rocha, Haroldo Luis Oliva
Dias Nascimento, Leonardo Augusto
Fleury Guedes, Mayra Machado
Guerra, Julia Esteves
author_facet de Almeida e Borges, Valéria Ferreira
Cotrim, Helma Pinchemel
Ferreira, Marcelo Simão
Caetano Marins, José Humberto
Gomes Rocha, Haroldo Luis Oliva
Dias Nascimento, Leonardo Augusto
Fleury Guedes, Mayra Machado
Guerra, Julia Esteves
author_sort de Almeida e Borges, Valéria Ferreira
collection PubMed
description
format Online
Article
Text
id pubmed-9252391
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Association for the Study of the Liver. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-92523912022-07-05 Cholangiopathy after severe COVID-19: what do we know so far? de Almeida e Borges, Valéria Ferreira Cotrim, Helma Pinchemel Ferreira, Marcelo Simão Caetano Marins, José Humberto Gomes Rocha, Haroldo Luis Oliva Dias Nascimento, Leonardo Augusto Fleury Guedes, Mayra Machado Guerra, Julia Esteves J Hepatol POSTER PRESENTATIONS: Thursday 23 June: Immune-mediated and cholestatic disease: Clinical aspects European Association for the Study of the Liver. Published by Elsevier B.V. 2022-07 2022-07-04 /pmc/articles/PMC9252391/ http://dx.doi.org/10.1016/S0168-8278(22)00981-3 Text en Copyright © 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle POSTER PRESENTATIONS: Thursday 23 June: Immune-mediated and cholestatic disease: Clinical aspects
de Almeida e Borges, Valéria Ferreira
Cotrim, Helma Pinchemel
Ferreira, Marcelo Simão
Caetano Marins, José Humberto
Gomes Rocha, Haroldo Luis Oliva
Dias Nascimento, Leonardo Augusto
Fleury Guedes, Mayra Machado
Guerra, Julia Esteves
Cholangiopathy after severe COVID-19: what do we know so far?
title Cholangiopathy after severe COVID-19: what do we know so far?
title_full Cholangiopathy after severe COVID-19: what do we know so far?
title_fullStr Cholangiopathy after severe COVID-19: what do we know so far?
title_full_unstemmed Cholangiopathy after severe COVID-19: what do we know so far?
title_short Cholangiopathy after severe COVID-19: what do we know so far?
title_sort cholangiopathy after severe covid-19: what do we know so far?
topic POSTER PRESENTATIONS: Thursday 23 June: Immune-mediated and cholestatic disease: Clinical aspects
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252391/
http://dx.doi.org/10.1016/S0168-8278(22)00981-3
work_keys_str_mv AT dealmeidaeborgesvaleriaferreira cholangiopathyafterseverecovid19whatdoweknowsofar
AT cotrimhelmapinchemel cholangiopathyafterseverecovid19whatdoweknowsofar
AT ferreiramarcelosimao cholangiopathyafterseverecovid19whatdoweknowsofar
AT caetanomarinsjosehumberto cholangiopathyafterseverecovid19whatdoweknowsofar
AT gomesrochaharoldoluisoliva cholangiopathyafterseverecovid19whatdoweknowsofar
AT diasnascimentoleonardoaugusto cholangiopathyafterseverecovid19whatdoweknowsofar
AT fleuryguedesmayramachado cholangiopathyafterseverecovid19whatdoweknowsofar
AT guerrajuliaesteves cholangiopathyafterseverecovid19whatdoweknowsofar